We report a case of symptomatic Torsades de pointes due to QTc prolongation
by Mibefradil, which potentially explains unexpected deaths related to thi
s drug. Multiple episodes of Torsades de pointes were documented in a 76-ye
ar-old woman with significant QTc prolongation of 0.53 s. After discontinua
tion of Mibefradil QTc intervals normalized and no further ventricular tach
yarrythmias were observed. We conclude that Mibefradil can cause QTc prolon
gation and life threatening ventricular dysrhythmias. (C) 2001 European Soc
iety of Cardiology. All rights reserved.